Cite
KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology.
MLA
Wei Wang, et al. “KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology.” PLoS ONE, vol. 7, no. 9, Sept. 2012, pp. 1–11. EBSCOhost, https://doi.org/10.1371/journal.pone.0044883.
APA
Wei Wang, Lin Ao, Rayburn, E. R., Hongxia Xu, Xiangrong Zhang, Xu Zhang, Subhasree Ashok Nag, Xuming Wu, Ming-Hai Wang, Hui Wang, Van Meir, E. G., Ruiwen Zhang, & Ahmad, A. (2012). KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology. PLoS ONE, 7(9), 1–11. https://doi.org/10.1371/journal.pone.0044883
Chicago
Wei Wang, Lin Ao, Elizabeth R. Rayburn, Hongxia Xu, Xiangrong Zhang, Xu Zhang, Subhasree Ashok Nag, et al. 2012. “KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology.” PLoS ONE 7 (9): 1–11. doi:10.1371/journal.pone.0044883.